Resources

Type of publications
Regions
Diseases

5255 results found

2017 ∙ SAGE

Should SAGE recommend the removal of the criterion that MCV2 only be given if MCV1 coverage is >80% for the introduction of routine measles second dose as stated in the 2009 measles vaccine position paper?

  • Evidence to recommendation table
  • Measles
Download:
2017 ∙ SAGE

Systematic literature review and meta-analyses of the benefits and risks of measles vaccination below 6 months of age

  • SAGE background document
  • Measles
Download:
2017 ∙ SAGE

Safety of the measles vaccine in young children and adolescents

  • GRADE table
  • GRADE
  • Measles
Download:
2017 ∙ SAGE

Duration of protection following measles immunization

  • GRADE table
  • GRADE
  • Measles
Download:
2017 ∙ SAGE

Should an additional dose of measles-containing vaccine be recommended for HIV-infected adolescents and adults?

  • GRADE table
  • Measles
Download:
2017 ∙ SAGE

Measles revaccination of HIV-infected children receiving highly active antiretroviral therapy

  • GRADE table
  • GRADE
  • Measles
Download:
2017 ∙ SAGE

Should HIV-infected children receiving highly active antiretroviral therapy be revaccinated against measles?

  • Evidence to recommendation table
  • Measles
Download:
2017 ∙ SAGE

Safety in HIV infected children

  • GRADE table
  • GRADE
  • Measles
Download:
2017 ∙ SAGE

Measles vaccines: WHO position paper

  • Position paper
  • Measles
Download:
2017 ∙ Philippe Duclos, Laure Dumolard, Noni MacDonald, Melanie Marti, Monica de Cola

Assessments of global drivers of vaccine hesitancy in 2014—Looking beyond safety concerns

  • Vaccine hesitancy
Download:
Loading...